Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bed bug infestation in a French university hospital: control strategy, financial impact and perspectives.

The Journal of hospital infection·2022

Same author

Endocrinology of bone mineralization: An update.

Annales d'endocrinologie·2021

Same author

Eating behaviours associated with glycaemic variability and fear of hypoglycaemia in adults with type 1 diabetes.

Diabetes & metabolism·2019

Same author

Annales d'endocrinologie·2017

Same author

Long-term efficacy of real-time continuous glucose monitoring in patients with brittle or high-hypoglycaemic-risk type 1 diabetes treated by insulin pump: A single-centre experience.

Diabetes & metabolism·2016

Same author

Deletion of CPEB1 Gene: A Rare but Recurrent Cause of Premature Ovarian Insufficiency.

The Journal of clinical endocrinology and metabolism·2016

Search research articles

Related Experiment Videos

[Postpartum and contraception after gestational diabetes].

¹Service d'endocrinologie, diabète et maladies métaboliques, Université de Bretagne occidentale, CHU Brest, Hôpital de la Cavale blanche, 29609 Brest cedex, France. veronique.kerlan@chu-brest.fr

Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction

|December 28, 2010

Summary

Postpartum monitoring of blood glucose is crucial for women with gestational diabetes. Breastfeeding and hormonal contraceptives generally do not significantly alter metabolic profiles, but intrauterine devices are recommended for those with risk factors like obesity or hypertension.

Related Experiment Videos

Area of Science:

Endocrinology
Reproductive Health
Metabolic Disorders

Context:

Gestational diabetes requires postpartum glycemic monitoring for complete normalization.
Limited research exists on breastfeeding and hormonal contraception's impact on postpartum metabolic profiles.
Associated risk factors necessitate careful contraceptive selection.

Purpose:

To review the postpartum management of women with a history of gestational diabetes.
To assess the influence of breastfeeding and hormonal contraceptives on maternal and child metabolic health.
To provide guidance on appropriate contraceptive choices considering associated risk factors.

Summary:

Postpartum glycemic control is essential for women with gestational diabetes.
Breastfeeding appears to have a neutral effect on maternal and child metabolic profiles.
Hormonal contraception, including combined and progestin-only methods, shows no significant impact on carbohydrate metabolism.
Intrauterine devices are a safe contraceptive option for women with obesity, hypertension, or dyslipidemia.

Impact:

Highlights the importance of continued glycemic surveillance after pregnancy.
Informs clinical practice regarding safe and effective contraception for women with gestational diabetes and comorbidities.
Emphasizes the need for individualized contraceptive counseling based on patient risk factors.